| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant chemotherapy for rectal cancer
|
Bujko, K.
|
|
|
21 |
12 |
p. 2443
|
artikel
|
| 2 |
Aprepitant: drug–drug interactions in perspective
|
Aapro, M.S.
|
|
|
21 |
12 |
p. 2316-2323
|
artikel
|
| 3 |
Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
|
Chan, A.
|
|
|
21 |
12 |
p. 2305-2315
|
artikel
|
| 4 |
Bevacizumab-induced regression of anaplastic meningioma
|
Puchner, M.J.A.
|
|
|
21 |
12 |
p. 2445-2446
|
artikel
|
| 5 |
Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients
|
Ronzoni, M.
|
|
|
21 |
12 |
p. 2382-2389
|
artikel
|
| 6 |
Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories
|
Fiegl, M.
|
|
|
21 |
12 |
p. 2410-2419
|
artikel
|
| 7 |
Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial
|
Hess, V.
|
|
|
21 |
12 |
p. 2390-2395
|
artikel
|
| 8 |
Decline in breast cancer incidence in the Flemish region of Belgium after a decline in hormonal replacement therapy
|
Renard, F.
|
|
|
21 |
12 |
p. 2356-2360
|
artikel
|
| 9 |
Editorial board
|
|
|
|
21 |
12 |
p. ii-iii
|
artikel
|
| 10 |
Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database
|
Italiano, A.
|
|
|
21 |
12 |
p. 2436-2441
|
artikel
|
| 11 |
Incidence of and survival following brain metastases among women with inflammatory breast cancer
|
Dawood, S.
|
|
|
21 |
12 |
p. 2348-2355
|
artikel
|
| 12 |
In this issue
|
|
|
|
21 |
12 |
p. 2299
|
artikel
|
| 13 |
Low expression of Mel-18 predicts poor prognosis in patients with breast cancer
|
Guo, B.-H.
|
|
|
21 |
12 |
p. 2361-2369
|
artikel
|
| 14 |
Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum–paclitaxel-based chemotherapy, the GINECO experience
|
Alexandre, J.
|
|
|
21 |
12 |
p. 2377-2381
|
artikel
|
| 15 |
Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel
|
Shitara, K.
|
|
|
21 |
12 |
p. 2403-2409
|
artikel
|
| 16 |
Prevention and treatment of pandemic influenza in cancer patients
|
Francisci, D.
|
|
|
21 |
12 |
p. 2301-2303
|
artikel
|
| 17 |
Quality of life in localised malignant melanoma
|
Schlesinger-Raab, A.
|
|
|
21 |
12 |
p. 2428-2435
|
artikel
|
| 18 |
Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma
|
Bendandi, M.
|
|
|
21 |
12 |
p. 2420-2427
|
artikel
|
| 19 |
SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer
|
Mayer, E.L.
|
|
|
21 |
12 |
p. 2370-2376
|
artikel
|
| 20 |
Severe novel influenza A (H1N1) infection in cancer patients
|
Hajjar, L.A.
|
|
|
21 |
12 |
p. 2333-2341
|
artikel
|
| 21 |
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
|
Soria, J.C.
|
|
|
21 |
12 |
p. 2324-2332
|
artikel
|
| 22 |
Splenic volume can be a novel predictive parameter for the prognosis of chronic lymphocytic leukemia?
|
Song, M.-K.
|
|
|
21 |
12 |
p. 2443-2445
|
artikel
|
| 23 |
Table of Contents
|
|
|
|
21 |
12 |
p. iv-v
|
artikel
|
| 24 |
The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
|
Fariña-Sarasqueta, A.
|
|
|
21 |
12 |
p. 2396-2402
|
artikel
|
| 25 |
The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab
|
Simkens, L.H.J.
|
|
|
21 |
12 |
p. 2447-2448
|
artikel
|
| 26 |
Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind, phase II comparative study (FINDER1)
|
Ohno, S.
|
|
|
21 |
12 |
p. 2342-2347
|
artikel
|
Tijdschrift beschrijving